ArticleFrontiers in immunology2021

Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells.

Audrey Wetzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.